Organizing and delivering treatment for ADHD

David Coghill, Wai Chen, Desiree Silva

Research output: Chapter in Book/Conference paperChapter

Abstract

Following diagnosis, all children with ADHD will require some form of intervention and most will require treatment over a relatively prolonged period of time. Before embarking on medicating a child for ADHD it is important that both the treating doctor and parent (carer) have a good understanding of the child’s ADHD; a full history which includes environmental exposures and stress in pregnancy and early childhood; exclusion of conditions that may mimic ADHD (although can often be associated with ADHD), a through assessment with includes information from several sources, and an assessment of comorbidities associated with ADHD. Managing ADHD can be a complex journey where good communication with your patient, family and other allied professionals will greatly enrich this journey. We review potential modes of action of ADHD medications which explain (i) why careful dose titration of stimulant and psychotropic medications is essential; (ii) why combination of stimulants and an SSRI can be effective in enhancing emotional regulation – given that 5HT plays a key role in OFC function; (iii) why combination of stimulants and antipsychotic can reduce emotionality, anxity, agitation and aggression – given that stimulants target D1 and alpha2A receptors, while anti-psychotics target D2 receptors; (iv) why guanfacine and clonidine – alpha 2A agonists - have a role in ADHD management as a monotherapy or combination therapy; and (v) the relevance of pharmacokinetics.
Original languageEnglish
Title of host publicationWorld Federation of ADHD guide
EditorsLuis Augusto Rohde, Jan K. Buitelaar, Manfred Gerlach, Stephen V. Faraone
Place of PublicationPorto Alegre
PublisherWorld Federation ADHD
Chapter5
Pages83-109
Publication statusPublished - 2019

Fingerprint

Guanfacine
Environmental Exposure
Clonidine
Aggression
Caregivers
Antipsychotic Agents
Action Potentials
Comorbidity
Therapeutics
Pharmacokinetics
History
Communication
Pregnancy

Cite this

Coghill, D., Chen, W., & Silva, D. (2019). Organizing and delivering treatment for ADHD. In L. A. Rohde, J. K. Buitelaar, M. Gerlach, & S. V. Faraone (Eds.), World Federation of ADHD guide (pp. 83-109). Porto Alegre: World Federation ADHD.
Coghill, David ; Chen, Wai ; Silva, Desiree. / Organizing and delivering treatment for ADHD. World Federation of ADHD guide. editor / Luis Augusto Rohde ; Jan K. Buitelaar ; Manfred Gerlach ; Stephen V. Faraone. Porto Alegre : World Federation ADHD, 2019. pp. 83-109
@inbook{010df470cec34511ac1628dded55e9e7,
title = "Organizing and delivering treatment for ADHD",
abstract = "Following diagnosis, all children with ADHD will require some form of intervention and most will require treatment over a relatively prolonged period of time. Before embarking on medicating a child for ADHD it is important that both the treating doctor and parent (carer) have a good understanding of the child’s ADHD; a full history which includes environmental exposures and stress in pregnancy and early childhood; exclusion of conditions that may mimic ADHD (although can often be associated with ADHD), a through assessment with includes information from several sources, and an assessment of comorbidities associated with ADHD. Managing ADHD can be a complex journey where good communication with your patient, family and other allied professionals will greatly enrich this journey. We review potential modes of action of ADHD medications which explain (i) why careful dose titration of stimulant and psychotropic medications is essential; (ii) why combination of stimulants and an SSRI can be effective in enhancing emotional regulation – given that 5HT plays a key role in OFC function; (iii) why combination of stimulants and antipsychotic can reduce emotionality, anxity, agitation and aggression – given that stimulants target D1 and alpha2A receptors, while anti-psychotics target D2 receptors; (iv) why guanfacine and clonidine – alpha 2A agonists - have a role in ADHD management as a monotherapy or combination therapy; and (v) the relevance of pharmacokinetics.",
keywords = "ADHD, medication, psychopharmacology",
author = "David Coghill and Wai Chen and Desiree Silva",
year = "2019",
language = "English",
pages = "83--109",
editor = "Rohde, {Luis Augusto } and Buitelaar, {Jan K. } and Gerlach, {Manfred } and Faraone, {Stephen V. }",
booktitle = "World Federation of ADHD guide",
publisher = "World Federation ADHD",

}

Coghill, D, Chen, W & Silva, D 2019, Organizing and delivering treatment for ADHD. in LA Rohde, JK Buitelaar, M Gerlach & SV Faraone (eds), World Federation of ADHD guide. World Federation ADHD, Porto Alegre, pp. 83-109.

Organizing and delivering treatment for ADHD. / Coghill, David; Chen, Wai; Silva, Desiree.

World Federation of ADHD guide. ed. / Luis Augusto Rohde; Jan K. Buitelaar; Manfred Gerlach; Stephen V. Faraone. Porto Alegre : World Federation ADHD, 2019. p. 83-109.

Research output: Chapter in Book/Conference paperChapter

TY - CHAP

T1 - Organizing and delivering treatment for ADHD

AU - Coghill, David

AU - Chen, Wai

AU - Silva, Desiree

PY - 2019

Y1 - 2019

N2 - Following diagnosis, all children with ADHD will require some form of intervention and most will require treatment over a relatively prolonged period of time. Before embarking on medicating a child for ADHD it is important that both the treating doctor and parent (carer) have a good understanding of the child’s ADHD; a full history which includes environmental exposures and stress in pregnancy and early childhood; exclusion of conditions that may mimic ADHD (although can often be associated with ADHD), a through assessment with includes information from several sources, and an assessment of comorbidities associated with ADHD. Managing ADHD can be a complex journey where good communication with your patient, family and other allied professionals will greatly enrich this journey. We review potential modes of action of ADHD medications which explain (i) why careful dose titration of stimulant and psychotropic medications is essential; (ii) why combination of stimulants and an SSRI can be effective in enhancing emotional regulation – given that 5HT plays a key role in OFC function; (iii) why combination of stimulants and antipsychotic can reduce emotionality, anxity, agitation and aggression – given that stimulants target D1 and alpha2A receptors, while anti-psychotics target D2 receptors; (iv) why guanfacine and clonidine – alpha 2A agonists - have a role in ADHD management as a monotherapy or combination therapy; and (v) the relevance of pharmacokinetics.

AB - Following diagnosis, all children with ADHD will require some form of intervention and most will require treatment over a relatively prolonged period of time. Before embarking on medicating a child for ADHD it is important that both the treating doctor and parent (carer) have a good understanding of the child’s ADHD; a full history which includes environmental exposures and stress in pregnancy and early childhood; exclusion of conditions that may mimic ADHD (although can often be associated with ADHD), a through assessment with includes information from several sources, and an assessment of comorbidities associated with ADHD. Managing ADHD can be a complex journey where good communication with your patient, family and other allied professionals will greatly enrich this journey. We review potential modes of action of ADHD medications which explain (i) why careful dose titration of stimulant and psychotropic medications is essential; (ii) why combination of stimulants and an SSRI can be effective in enhancing emotional regulation – given that 5HT plays a key role in OFC function; (iii) why combination of stimulants and antipsychotic can reduce emotionality, anxity, agitation and aggression – given that stimulants target D1 and alpha2A receptors, while anti-psychotics target D2 receptors; (iv) why guanfacine and clonidine – alpha 2A agonists - have a role in ADHD management as a monotherapy or combination therapy; and (v) the relevance of pharmacokinetics.

KW - ADHD

KW - medication

KW - psychopharmacology

M3 - Chapter

SP - 83

EP - 109

BT - World Federation of ADHD guide

A2 - Rohde, Luis Augusto

A2 - Buitelaar, Jan K.

A2 - Gerlach, Manfred

A2 - Faraone, Stephen V.

PB - World Federation ADHD

CY - Porto Alegre

ER -

Coghill D, Chen W, Silva D. Organizing and delivering treatment for ADHD. In Rohde LA, Buitelaar JK, Gerlach M, Faraone SV, editors, World Federation of ADHD guide. Porto Alegre: World Federation ADHD. 2019. p. 83-109